Translating mRNA
Educational Webinar Series
The Pfizer Vaccines US Medical Affairs Team invites you to attend an educational webinar series titled Translating mRNA, which is focused on providing education on COVID-19 and vaccination. The webinar series is designed to communicate scientific information which may include recent study results to help inform healthcare providers regarding Pfizer and BioNTech COVID-19 vaccines and burden of disease.
The webinar series will include a live question-and-answer session with Pfizer medical experts.
We are hosting a Translating mRNA webinar on the topic below
Continued Impact of COVID-19 in Adults Under 65 Years of Age
Date and Time:
Thursday, 20 March 2025: 12:00 pm – 12:30 pm ET
Speaker: Rajeev M Nepal, PhD
US Medical Director, Pfizer mRNA Vaccines, Medical and Scientific Affairs
Target Audience: All healthcare professionals including physicians, nurse practitioners, pharmacists, and physician assistants.
Continuing medical education credit is NOT associated with this event.
Prior Translating mRNA Webinar Videos are AvailableIndication
COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine indicated for
active immunization to prevent coronavirus disease 2019 (COVID-19)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in individuals 12 years of age and older.
Emergency use Authorization
Emergency uses of COVID-19 vaccines from BioNTech and Pfizer,
including Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula), have
not been approved or licensed by FDA, but have been authorized by FDA,
under an Emergency Use Authorization (EUA) to prevent Coronavirus
Disease 2019 (COVID-19) in individuals 6 months of age and older.
Emergency uses are only authorized for the duration of the declaration
that circumstances exist justifying the authorization of emergency use of
the medical products under Section 564(b)(1) of the FD&C Act unless the
declaration is terminated or authorization revoked sooner.
For most recent US Full Prescribing Information and Fact Sheets, please
visit
www.cvdvaccine-us.com